Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-08

Clinical Trial Update: A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vinflunine in patients with metastatic bladder cancer and impaired renal function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinflunine (vinflunine)

Snippet

Sponsor: Dr Anders Ullén | Conditions: Urothelial Carcinoma, Bladder Cancer | Phase 2 | Status: COMPLETED